Evidence map›Paper›PMID 33425768›Full record

ArticleFrontiers in oncology2020

The Roles of Beclin 1 Expression in Gastric Cancer: A Marker for Carcinogenesis, Aggressive Behaviors and Favorable Prognosis, and a Target of Gene Therapy.

Hua-Chuan Zheng, Shuang Zhao, Hang Xue, En-Hong Zhao, Hua-Mao Jiang, Chang-Lai Hao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. The Biological Role and Clinical Significance of BECLIN-1 in Cancer.International journal of molecular sciences · 2025
    Review
  6. Autophagy Protease ATG4D Facilitates Proliferation and Malignancy of Osteosarcoma Cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hua-Chuan ZhengDepartment of Oncology and Experimental Center, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Shuang ZhaoDepartment of Oncology and Experimental Center, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Hang XueDepartment of Oncology and Experimental Center, The Affiliated Hospital of Chengde Medical University, Chengde, China.
En-Hong ZhaoDepartment of Surgery, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Hua-Mao JiangDepartment of Urology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Chang-Lai HaoDepartment of Hematology, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Chengde Medical University · CNJinzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beclin 1 is encoded by

Indexed as

aggressive behaviorsBeclin 1carcinogenesisgastric cancergene therapyprognosis

Identifiers

PMID33425768
PMCPMC7787063
OpenAlexW3114786092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.